L-arginine inhalation - PARI
Latest Information Update: 12 Apr 2007
At a glance
- Originator PARI
- Class Basic amino acids; Diamino amino acids; Essential amino acids
- Mechanism of Action Nitric oxide synthase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Clinical Phase Unknown Cystic fibrosis
Most Recent Events
- 01 Dec 2006 Clinical trials in Cystic fibrosis in USA (Inhalation)